230 related articles for article (PubMed ID: 26753814)
1. Cyclic RGD peptidomimetics containing 4- and 5-amino-cyclopropane pipecolic acid (CPA) templates as dual αVβ3 and α5β1 integrin ligands.
Sernissi L; Trabocchi A; Scarpi D; Bianchini F; Occhiato EG
Bioorg Med Chem; 2016 Feb; 24(4):703-11. PubMed ID: 26753814
[TBL] [Abstract][Full Text] [Related]
2. Cyclopropane pipecolic acids as templates for linear and cyclic peptidomimetics: application in the synthesis of an Arg-Gly-Asp (RGD)-containing peptide as an αvβ3 integrin ligand.
Sernissi L; Petrović M; Scarpi D; Guarna A; Trabocchi A; Bianchini F; Occhiato EG
Chemistry; 2014 Aug; 20(35):11187-203. PubMed ID: 25069617
[TBL] [Abstract][Full Text] [Related]
3. Stereodivergent synthesis of 5-aminopipecolic acids and application in the preparation of a cyclic RGD peptidomimetic as a nanomolar α
Sernissi L; Ricci L; Scarpi D; Bianchini F; Arosio D; Contini A; Occhiato EG
Org Biomol Chem; 2018 May; 16(18):3402-3414. PubMed ID: 29675532
[TBL] [Abstract][Full Text] [Related]
4. Cyclic RGD and
Panzeri S; Arosio D; Gazzola S; Belvisi L; Civera M; Potenza D; Vasile F; Kemker I; Ertl T; Sewald N; Reiser O; Piarulli U
Molecules; 2020 Dec; 25(24):. PubMed ID: 33339382
[TBL] [Abstract][Full Text] [Related]
5. Modulation of αvβ₃- and α₅β₁-integrin-mediated adhesion by dehydro-β-amino acids containing peptidomimetics.
Tolomelli A; Baiula M; Belvisi L; Viola A; Gentilucci L; Troisi S; Dattoli SD; Spampinato S; Civera M; Juaristi E; Escudero M
Eur J Med Chem; 2013 Aug; 66():258-68. PubMed ID: 23811088
[TBL] [Abstract][Full Text] [Related]
6. Cyclic isoDGR and RGD peptidomimetics containing bifunctional diketopiperazine scaffolds are integrin antagonists.
Panzeri S; Zanella S; Arosio D; Vahdati L; Dal Corso A; Pignataro L; Paolillo M; Schinelli S; Belvisi L; Gennari C; Piarulli U
Chemistry; 2015 Apr; 21(16):6265-71. PubMed ID: 25761230
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
[TBL] [Abstract][Full Text] [Related]
8. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.
Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C
Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378
[TBL] [Abstract][Full Text] [Related]
9. Determination of the binding epitope of RGD-peptidomimetics to αvβ3 and α(IIb)β3 integrin-rich intact cells by NMR and computational studies.
Guzzetti I; Civera M; Vasile F; Araldi EM; Belvisi L; Gennari C; Potenza D; Fanelli R; Piarulli U
Org Biomol Chem; 2013 Jun; 11(23):3886-93. PubMed ID: 23657523
[TBL] [Abstract][Full Text] [Related]
10. Functionalized cyclic RGD peptidomimetics: conjugable ligands for αvβ3 receptor imaging.
Arosio D; Manzoni L; Araldi EM; Caprini A; Monferini E; Scolastico C
Bioconjug Chem; 2009 Aug; 20(8):1611-7. PubMed ID: 21141806
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophoric modifications lead to superpotent αvβ3 integrin ligands with suppressed α5β1 activity.
Neubauer S; Rechenmacher F; Brimioulle R; Di Leva FS; Bochen A; Sobahi TR; Schottelius M; Novellino E; Mas-Moruno C; Marinelli L; Kessler H
J Med Chem; 2014 Apr; 57(8):3410-7. PubMed ID: 24654918
[TBL] [Abstract][Full Text] [Related]
12. Development of isoxazoline-containing peptidomimetics as dual αvβ3 and α5β1 integrin ligands.
Tolomelli A; Gentilucci L; Mosconi E; Viola A; Dattoli SD; Baiula M; Spampinato S; Belvisi L; Civera M
ChemMedChem; 2011 Dec; 6(12):2264-72. PubMed ID: 21953988
[TBL] [Abstract][Full Text] [Related]
13. αvβ3- or α5β1-Integrin-Selective Peptidomimetics for Surface Coating.
Mas-Moruno C; Fraioli R; Rechenmacher F; Neubauer S; Kapp TG; Kessler H
Angew Chem Int Ed Engl; 2016 Jun; 55(25):7048-67. PubMed ID: 27258759
[TBL] [Abstract][Full Text] [Related]
14. A selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasion.
Hoffmann S; He S; Jin M; Ehren M; Wiedemann P; Ryan SJ; Hinton DR
BMC Ophthalmol; 2005 Jun; 5():16. PubMed ID: 15987521
[TBL] [Abstract][Full Text] [Related]
15. Morpholine-based RGD-cyclopentapeptides as alphavbeta3/alphavbeta5 integrin ligands: role of configuration towards receptor binding affinity.
Cini N; Trabocchi A; Menchi G; Bottoncetti A; Raspanti S; Pupi A; Guarna A
Bioorg Med Chem; 2009 Feb; 17(4):1542-9. PubMed ID: 19195898
[TBL] [Abstract][Full Text] [Related]
16. A molecular toolkit for the functionalization of titanium-based biomaterials that selectively control integrin-mediated cell adhesion.
Rechenmacher F; Neubauer S; Mas-Moruno C; Dorfner PM; Polleux J; Guasch J; Conings B; Boyen HG; Bochen A; Sobahi TR; Burgkart R; Spatz JP; Fässler R; Kessler H
Chemistry; 2013 Jul; 19(28):9218-23. PubMed ID: 23744802
[TBL] [Abstract][Full Text] [Related]
17. Mimicking bone extracellular matrix: integrin-binding peptidomimetics enhance osteoblast-like cells adhesion, proliferation, and differentiation on titanium.
Fraioli R; Rechenmacher F; Neubauer S; Manero JM; Gil J; Kessler H; Mas-Moruno C
Colloids Surf B Biointerfaces; 2015 Apr; 128():191-200. PubMed ID: 25637448
[TBL] [Abstract][Full Text] [Related]
18. Grafting aminocyclopentane carboxylic acids onto the RGD tripeptide sequence generates low nanomolar alphaVbeta3/alphaVbeta5 integrin dual binders.
Casiraghi G; Rassu G; Auzzas L; Burreddu P; Gaetani E; Battistini L; Zanardi F; Curti C; Nicastro G; Belvisi L; Motto I; Castorina M; Giannini G; Pisano C
J Med Chem; 2005 Dec; 48(24):7675-87. PubMed ID: 16302808
[TBL] [Abstract][Full Text] [Related]
19. Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist.
Belvisi L; Riccioni T; Marcellini M; Vesci L; Chiarucci I; Efrati D; Potenza D; Scolastico C; Manzoni L; Lombardo K; Stasi MA; Orlandi A; Ciucci A; Nico B; Ribatti D; Giannini G; Presta M; Carminati P; Pisano C
Mol Cancer Ther; 2005 Nov; 4(11):1670-80. PubMed ID: 16275988
[TBL] [Abstract][Full Text] [Related]
20. Targeting integrins αvβ3 and α5β1 with new β-lactam derivatives.
Galletti P; Soldati R; Pori M; Durso M; Tolomelli A; Gentilucci L; Dattoli SD; Baiula M; Spampinato S; Giacomini D
Eur J Med Chem; 2014 Aug; 83():284-93. PubMed ID: 24973662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
